Lillia Company Profile

Background

Overview

Lillia is an AI-driven platform dedicated to transforming chronic disease management, particularly focusing on diabetes and related metabolic conditions. Established in 2020 through the merger of Qatar-based Droobi Health LLC and India-based Smit.fit, Lillia combines deep clinical expertise with cutting-edge AI innovation across the GCC region and India.

Mission and Vision

Lillia's mission is to empower individuals living with chronic conditions to lead fulfilling lives by providing continuous, adaptive care that drives real and lasting lifestyle changes. The company's vision is to lower the global chronic disease burden through AI-driven, clinically proven solutions.

Primary Area of Focus

Lillia specializes in chronic disease management, with a particular emphasis on diabetes and weight-related conditions. The platform offers personalized care journeys tailored to individual metabolic profiles and lifestyles, aiming to prevent, manage, and reverse chronic conditions.

Industry Significance

Since its inception, Lillia has supported over 40,000 individuals across the GCC region and India, partnering with 20 institutional clients in the healthcare, corporate, insurance, and public sectors. The platform has demonstrated significant clinical outcomes, with 85% of high-risk users experiencing a reduction in blood sugar levels and 80% achieving a 5% weight loss within three months.

Key Strategic Focus

Core Objectives

Personalized Care: Developing AI-driven solutions that provide hyper-personalized care plans based on individual health data and behaviors.

Clinical Outcomes: Achieving measurable health improvements, including blood sugar reduction and weight loss, to enhance patient quality of life.

Scalability: Expanding services across the MENA and South East Asia regions over the next two years.

Specific Areas of Specialization

Diabetes Management: Offering comprehensive solutions for diabetes prevention, management, and reversal.

Weight Management: Providing programs aimed at sustainable weight loss and obesity prevention.

Key Technologies Utilized

Artificial Intelligence: Leveraging AI to deliver personalized care and predictive analytics.

Digital Twin Technology: Developing digital replicas of patients to monitor and predict health outcomes.

Primary Markets Targeted

Healthcare Providers: Enhancing patient engagement and outcomes through AI-driven solutions.

Insurers: Reducing healthcare costs by improving chronic disease management.

Corporations and Public Sector Entities: Implementing wellness programs to promote employee health and productivity.

Financials and Funding

Funding History

Lillia has secured funding through various rounds, including a notable grant from the Qatar Research, Development and Innovation (QRDI) Council in February 2025. The exact total funds raised and details of other funding rounds are not publicly disclosed.

Utilization of Capital

The capital raised is intended to support the development of Lillia's digital twin technology and AI-driven solutions, as well as to facilitate expansion into new markets, particularly in the MENA and South East Asia regions.

Pipeline Development

Key Pipeline Candidates

Digital Twin Technology: Developing AI-driven digital twins to provide predictive capabilities for real-time risk monitoring and precision medication.

Stages of Development

Digital Twin: Currently under development, with plans to launch in the near future.

Target Conditions

Chronic Diseases: Focusing on diabetes and related metabolic conditions.

Anticipated Milestones

Expansion: Plans to expand services across MENA and South East Asia regions over the next two years.

Technological Platform and Innovation

Proprietary Technologies

AI-Powered Platform: Utilizing artificial intelligence to deliver personalized chronic disease management solutions.

Digital Twin Technology: Creating digital replicas of patients to monitor and predict health outcomes.

Significant Scientific Methods

Behavior-Change Nudging Model: Employing AI-driven prompts and actionable insights to build and sustain healthy habits.

Glucose Prediction: Developing real-time forecasting of glucose fluctuations with high accuracy, powered by extensive user data.

Leadership Team

Key Executives

Sujit Chakrabarty: Founder and CEO. With a background in healthcare and technology, Sujit has been instrumental in Lillia's growth and strategic direction.

Arati Joshi: Chief Medical Officer. Arati brings extensive experience in clinical medicine and public health, contributing to the development of Lillia's health programs.

Recent Leadership Changes

Specific details regarding recent leadership changes are not publicly disclosed.

Competitor Profile

Market Insights and Dynamics

The chronic disease management market is experiencing significant growth, driven by the increasing prevalence of conditions like diabetes and obesity. There is a rising demand for digital health solutions that offer personalized care and predictive analytics.

Competitor Analysis

Procare Solutions: Offers comprehensive childcare management software, focusing on operational efficiency and parent engagement.

Brightwheel: Provides early education software with tools for assessment, communication, and photo sharing.

Tadpoles: Specializes in childcare and preschool management through mobile technology.

Kangarootime: Delivers childcare management solutions with features like automated check-in and tuition billing.

Famly: Offers a digital platform for daycares and nurseries, focusing on administrative tasks and parent communication.

Strategic Collaborations and Partnerships

Lillia collaborates with various healthcare providers, pharmaceutical companies, insurers, and public sector entities to enhance chronic disease management and improve patient outcomes.

Operational Insights

Lillia's AI-driven platform offers a scalable solution for chronic disease management, differentiating itself through personalized care plans and predictive analytics. The company's focus on digital twin technology and behavior-change models positions it as a leader in the health-tech space.

Strategic Opportunities and Future Directions

Lillia aims to expand its services across the MENA and South East Asia regions, leveraging its AI-driven solutions to address the growing burden of chronic diseases. The development of digital twin technology and agentic AI solutions presents opportunities for real-time risk monitoring and precision medication, further enhancing patient care.